Wilfactin

Wilfactin is a human von Willebrand factor product used to treat von Willebrand disease, a bleeding disorder. It helps control and prevent bleeding episodes by replacing the missing or defective protein. Suitable for patients requiring factor replacement therapy.

Wilfactin is used to manage and prevent bleeding in individuals with von Willebrand disease, a condition where blood does not clot properly. It provides the missing von Willebrand factor, which is essential for normal blood clotting. This medication is typically used during surgeries, dental procedures, or in response to injury to reduce bleeding risk. It may also be used for long-term prevention in certain cases.

After administration, Wilfactin works by increasing levels of von Willebrand factor in the blood, supporting the clotting process. Patients may notice reduced bleeding episodes or improved clotting function over time. The effects vary by individual and depend on the severity of the condition and the dose received.

Wilfactin should be handled with care to avoid contamination. It is typically administered by a healthcare professional in a clinical setting. Patients should inform their doctor of any allergies or previous reactions to blood products. Regular monitoring may be required to assess response and adjust treatment as needed.

Wilfactin may interact with other medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. Patients should inform their healthcare provider about all medications they are taking. No specific food or alcohol interactions have been widely reported, but caution is advised with substances that may increase bleeding risk.